Clinical trial
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
NCT03950076 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
- Lead sponsor
- Population Health Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 20, 2019
- Completion date
- July 22, 2026
- Enrollment
- 948 (actual)
- Sites
- 152
Conditions
As the registry lists them; a condition with its own page is linked.